Compare NPCE & FBYD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NPCE | FBYD |
|---|---|---|
| Founded | 1997 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 490.2M | 497.7M |
| IPO Year | 2021 | 2023 |
| Metric | NPCE | FBYD |
|---|---|---|
| Price | $14.69 | $7.55 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.33 | N/A |
| AVG Volume (30 Days) | ★ 163.9K | 78.4K |
| Earning Date | 05-12-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ 0.04 |
| Revenue | ★ $99,986,000.00 | $14,896,000.00 |
| Revenue This Year | $0.90 | N/A |
| Revenue Next Year | $24.46 | N/A |
| P/E Ratio | ★ N/A | $187.25 |
| Revenue Growth | 25.13 | ★ 120.85 |
| 52 Week Low | $9.22 | $3.71 |
| 52 Week High | $19.60 | $29.02 |
| Indicator | NPCE | FBYD |
|---|---|---|
| Relative Strength Index (RSI) | 51.45 | 26.86 |
| Support Level | $13.74 | $5.73 |
| Resistance Level | $15.27 | $8.65 |
| Average True Range (ATR) | 0.59 | 0.90 |
| MACD | 0.10 | -0.11 |
| Stochastic Oscillator | 66.86 | 6.04 |
NeuroPace Inc is a medical device company focused on transforming the lives of people living with epilepsy by reducing or eliminating the occurrence of seizures. The company offers the RNS System, a brain-responsive neuromodulation system that continuously monitors and analyzes the brain's electrical activity and delivers personalized, real-time electrical pulses at the seizure source to prevent seizures. The RNS System includes the RNS neurostimulator, cortical strip leads, depth leads, a Patient Remote Monitor, and other implantable and non-implantable accessories used during implant procedures. The company also provides the Physician Tablet, Patient Data Management System, and the nSight Platform to facilitate ongoing patient monitoring and support clinicians in managing patient care.
Falcons Beyond Global Inc is a visionary entertainment and technology enterprise. The group designs, develops, engineers, delivers, and commercializes immersive physical and digital experiences for brands, developers, and destination operators world-wide, as well as for its own portfolio of entertainment and technology concepts. The Company has five operating segments: Falcon's Creative Group, Destinations Operations, PDP, Falcon's Beyond Brands, and Falcon's Attractions. It earns the majority of the revenue from Falcon's Creative Group segment.